Kratochwil, C., Bruchertseifer, F., Rathke, H., Hohenfellner, M., Giesel, F. L., Haberkorn, U., & Morgenstern, A. (2018). Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: Swimmer-plot analysis suggests efficacy regarding duration of tumor control. Journal of nuclear medicine, 59(5), . https://doi.org/10.2967/jnumed.117.203539
Chicago-Zitierstil (17. Ausg.)Kratochwil, Clemens, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn, und Alfred Morgenstern. "Targeted α-therapy of Metastatic Castration-resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-plot Analysis Suggests Efficacy Regarding Duration of Tumor Control." Journal of Nuclear Medicine 59, no. 5 (2018). https://doi.org/10.2967/jnumed.117.203539.
MLA-Zitierstil (9. Ausg.)Kratochwil, Clemens, et al. "Targeted α-therapy of Metastatic Castration-resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-plot Analysis Suggests Efficacy Regarding Duration of Tumor Control." Journal of Nuclear Medicine, vol. 59, no. 5, 2018, https://doi.org/10.2967/jnumed.117.203539.